Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the ...

In light of recent statements by Opposition Leader Kamla Persad-Bissessar and Health Minister Terrence Deyalsingh regarding ...

The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...

The Covid-19 pandemic saw an uptake in alternative trial designs and accelerated recruitment – will this be replicated with ...

Uses mRNA technology, such as that employed by Covid-19 vaccines, to instruct the immune system to recognise healthy cells versus tumour cells. In a phase-one clinical trial involving 19 patients ...

Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Global COVID-19 Clinical Trials Market by Product (Therapeutics, Vaccines), Phase (Phase I, Phase II, Phase III) - Forecast 2024-2030" report has ...

Phase 1 clinical trials have been launched across 34 research ... “I think people need to remember the COVID-19 vaccine worked for cancer patients. It reduced mortality more than the general ...

The following is a summary of “Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials,” published in the September 2024 issue of Infectious Disease by Janes et al.

The vaccine developed by Sinopharm shows good immunity protection against the virus, says the Chinese company.

Oxford Vaccine Rollout At the very end of December, UK healthcare regulator the Medicines and Healthcare Products Regulatory ...

The newly approved vaccine targets multiple circulating variants, promising enhanced protection and availability across ...